Apollomics Inc.
Business
Apollomics Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic drug candidates. It focuses on developing small-molecule oncology product candidates and conducting preclinical and clinical development activities, supported by regulatory and safety programs. Its operations are organized around research and development, clinical development and testing, outsourced manufacturing and quality control, and collaborations and licensing arrangements with third parties. Apollomics conducts clinical trials and seeks partners internationally, with activities and distribution managed through strategic collaborators, contract research organizations and contract manufacturers in multiple countries.
Summary from filing dated 2025-04-03
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-10.94M |
| Total assets | $6.71M |
| Total liabilities | — |
| Stockholders' equity | — |
| Operating cash flow | — |